Quarterly report pursuant to Section 13 or 15(d)

Schedule of Accounts Payable and Accrued Liabilities (Details)

v3.22.1
Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)
Apr. 30, 2022
Jul. 31, 2021
Balance Sheet Details    
Research and development costs $ 2,391,304 $ 4,206,926
Professional services fees 664,035 1,229,040
Other 90,489 125,679
Total $ 3,145,828 $ 5,561,645